FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:146-147 July 12, 2001 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The study of the transplantation of embryonic dopamine neurons for severe Parkinson's disease reported by Freed et al. (March 8 issue)¹ revealed no benefit as measured on the basis of the primary outcome variable. In addition, severe dyskinesias developed in some patients. We believe it is important to not rush to judgment in evaluating neuronal transplantation in Parkinson's disease on the basis of the results of a single study.

The outcome variable — a subjective global rating of the change in the severity of the disease — was assessed with the use of a scale that was . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Wechsler, L. R., Kondziolka, D. (2003). Cell Therapy: Replacement. Stroke 34: 2081-2082 [Full Text]  
• Redmond, D. E. Jr. (2002). Book Review: Cellular Replacement Therapy for Parkinson's Disease--Where We Are Today?. Neuroscientist 8: 457-488 [Abstract]  
• Evers, K. (2002). European Perspectives on Therapeutic Cloning. NEJM 346: 1579-1582 [Full Text]  
• Jankovic, J. (2001). Surgery for Parkinson Disease and Other Movement Disorders: Benefits and Limitations of Ablation, Stimulation, Restoration, and Radiation. Arch Neurol 58: 1970-1972 [Full Text]